IL182745A - A very porous solid capsule that crumbles quickly and a method for its preparation consists of the preparation of the powder and freezing-drying - Google Patents

A very porous solid capsule that crumbles quickly and a method for its preparation consists of the preparation of the powder and freezing-drying

Info

Publication number
IL182745A
IL182745A IL182745A IL18274507A IL182745A IL 182745 A IL182745 A IL 182745A IL 182745 A IL182745 A IL 182745A IL 18274507 A IL18274507 A IL 18274507A IL 182745 A IL182745 A IL 182745A
Authority
IL
Israel
Prior art keywords
solid
water
dosage form
powder
components
Prior art date
Application number
IL182745A
Other languages
English (en)
Hebrew (he)
Other versions
IL182745A0 (en
Original Assignee
Pantec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL182745(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pantec Ag filed Critical Pantec Ag
Publication of IL182745A0 publication Critical patent/IL182745A0/en
Publication of IL182745A publication Critical patent/IL182745A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL182745A 2004-10-28 2007-04-23 A very porous solid capsule that crumbles quickly and a method for its preparation consists of the preparation of the powder and freezing-drying IL182745A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105381 2004-10-28
PCT/EP2005/055591 WO2006045830A1 (en) 2004-10-28 2005-10-27 A highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a podwer and a freezedrying step

Publications (2)

Publication Number Publication Date
IL182745A0 IL182745A0 (en) 2007-07-24
IL182745A true IL182745A (en) 2010-06-30

Family

ID=34929781

Family Applications (1)

Application Number Title Priority Date Filing Date
IL182745A IL182745A (en) 2004-10-28 2007-04-23 A very porous solid capsule that crumbles quickly and a method for its preparation consists of the preparation of the powder and freezing-drying

Country Status (18)

Country Link
US (1) US8802145B2 (de)
EP (1) EP1804764B1 (de)
JP (1) JP4980228B2 (de)
KR (1) KR101379297B1 (de)
CN (2) CN101065105A (de)
AT (1) ATE398444T1 (de)
BR (1) BRPI0517256B8 (de)
CA (1) CA2585426C (de)
CY (1) CY1108343T1 (de)
DE (1) DE602005007624D1 (de)
DK (1) DK1804764T3 (de)
ES (1) ES2308566T3 (de)
HK (1) HK1171364A1 (de)
IL (1) IL182745A (de)
PL (1) PL1804764T3 (de)
PT (1) PT1804764E (de)
SI (1) SI1804764T1 (de)
WO (1) WO2006045830A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
CN106666722B (zh) * 2017-03-13 2019-03-22 广州正广生物科技有限公司 一种螺旋藻片及其制备方法
ES2930199T3 (es) 2018-10-15 2022-12-07 Aprecia Pharmaceuticals LLC Método y sistema para formar una forma farmacéutica dentro de un envase
PL3927322T3 (pl) * 2019-02-22 2024-02-05 Catalent U.K. Swindon Zydis Limited Minimalizacja napowietrzania zawiesin podczas mieszania typu in-line
MX2021009845A (es) 2019-02-22 2021-09-10 Catalent Uk Swindon Zydis Ltd Minimizacion de la aglomeracion de material de revestimiento de particula de medicamento durante el almacenaje para estabilizar los tiempos de desintegracion de productos farmaceuticos.
CN113490486A (zh) 2019-02-22 2021-10-08 康特伦英国斯温顿捷迪斯有限公司 最小化团聚、曝气和保持包含布洛芬的药物组合物的包衣
CA3129404A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
ATE24964T1 (de) * 1981-12-11 1987-01-15 Wyeth John & Brother Ltd Verfahren zur herstellung von festen formgegenstaenden.
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
JPH0948726A (ja) * 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
CN1154479C (zh) * 1996-06-14 2004-06-23 协和发酵工业株式会社 口腔内快速崩解片剂
US5976577A (en) * 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
DE19931708A1 (de) * 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
TR200200313T2 (tr) * 1999-08-17 2002-04-22 Novartis Consumer Health S.A. Hızla çözünen dozaj formu ve bunun yapım prosesi.
EP1166655A1 (de) * 2000-06-19 2002-01-02 Société des Produits Nestlé S.A. Brett-stabiles oder gekühltes Schaumprodukt und Verfahren zur seiner Herstellung
CN1290525A (zh) * 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US6509040B1 (en) * 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
CN1197556C (zh) * 2003-02-12 2005-04-20 刘智 一种防治放疗、化疗呕吐的口腔快速崩解片剂及制备方法
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof

Also Published As

Publication number Publication date
JP4980228B2 (ja) 2012-07-18
CN101065105A (zh) 2007-10-31
US20090062241A1 (en) 2009-03-05
BRPI0517256B1 (pt) 2018-11-21
PT1804764E (pt) 2008-09-11
KR101379297B1 (ko) 2014-04-10
CA2585426C (en) 2013-05-14
US8802145B2 (en) 2014-08-12
CN102631289A (zh) 2012-08-15
CY1108343T1 (el) 2014-02-12
ES2308566T3 (es) 2008-12-01
IL182745A0 (en) 2007-07-24
ATE398444T1 (de) 2008-07-15
EP1804764B1 (de) 2008-06-18
DE602005007624D1 (de) 2008-07-31
CN102631289B (zh) 2016-05-04
JP2008517979A (ja) 2008-05-29
KR20070069179A (ko) 2007-07-02
SI1804764T1 (sl) 2008-10-31
PL1804764T3 (pl) 2008-11-28
BRPI0517256A (pt) 2008-10-07
DK1804764T3 (da) 2008-09-29
HK1171364A1 (zh) 2013-03-28
CA2585426A1 (en) 2006-05-04
BRPI0517256B8 (pt) 2021-05-25
EP1804764A1 (de) 2007-07-11
WO2006045830A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
CA2585426C (en) A highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a powder and a freezedrying step
EP0893992B1 (de) Schnell zerfallende orale dosierungsform
US7182959B2 (en) Rapidly dissolving dosage form and process for making same
Khanna et al. Fast dissolving tablets-A novel approach
KR20000023713A (ko) 속붕괴성 압축 성형물 및 그의 제조법
AU1931999A (en) Process for manufacturing bite-dispersion tablets
RU2273472C2 (ru) Лекарственный состав, быстро распадающийся в ротовой полости, и способ его изготовления
WO2003086343A2 (en) Fast disintegrating oral dosage forms
Arunachalam et al. Fast dissolving drug delivery system: A review
EP1699441B1 (de) Verfahren zur herstellung von schnell auflösenden tabletten
Kumar et al. Fast dissolving tablets: patient compliance dosage forms
EP1401403B1 (de) Arzneimittel enthaltend einen schmelzbaren kern in einer filmartigen verkapselung aus hydroxypropylmethylcellulose
Hemraj et al. Fast Dissolving Tablets-A Novel Approach
JP2008133294A (ja) 口腔内崩壊型錠剤
Umasankar et al. Fast dissolving tablet–review article
CA2250115C (en) Fast disintegrating oral dosage form
Suthar et al. FAST DISSOLVING TABLET: A REVIEW FAST DISSOLVING TABLET: A REVIEW
Chowdary et al. Available online at www. JGTPS. com

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees